Details of the Drug
General Information of Drug (ID: DMB5VQK)
| Drug Name |
1,4-dideoxy-1,4-imino-D-arabinito
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
1,4-dideoxy-1,4-imino-d-arabinitol; imino-D-arabinitol; CHEMBL80254; 3,4-Pyrrolidinediol, 2-(hydroxymethyl-14C)-, (2R,3R,4R)-; (2R,3R,4R)-2-(hydroxymethyl)pyrrolidine-3,4-diol; 259140-24-4; (2R,3R,4R)-2-Hydroxymethyl-pyrrolidine-3,4-diol; BDBM50031485; AC1L9PZY; 100937-52-8; DAB-1; Lopac0_000366; MLS002153179; SCHEMBL143519; CHEMBL305131; DTXSID10180589; OQEBIHBLFRADNM-UOWFLXDJSA-N; HMS2233K17; ZINC1492250; 1,4-Dideoxy-1,4-imino-arabinitol; BDBM50016703
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 133.15 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -1.7 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 4 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


